Document resource
In the recent editorial on middle meningeal artery embolization for chronic subdural hematoma,1 Levitt et al assert that the three recently published randomized trials of middle meningeal artery embolization (MMAE) indicate that the treatment is effective and should be considered routinely in the course of clinical care, particularly as an adjunct to surgical treatment. I have great admiration for the trialists and the hard work and expertise that completing these trials required. We must not allow our enthusiasm for this procedure to blind us to the actual results of this high quality research.